Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Asby RJ"'
Autor:
Gupta, S, Dovey, OM, Domingues, AF, Cyran, OW, Cash, CM, Giotopoulos, G, Rak, J, Cooper, J, Gozdecka, M, Asby, RJ, Al-Jabery, N, Hernandez, V, Prabakaran, S, Huntly, BJ, Vassiliou, GS, Pina, C
Competing Interest Statement: VH-H is co-Founder and CSO of Axovia Therapeutics. SP is the CEO of NonExomics, Inc. Axovia and NonExomics did not provide funding to this study, and did not influence study design, execution, data analysis or interpreta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______900::f0ab918d94e6629d17100ad8e331b4bd
https://bura.brunel.ac.uk/handle/2438/24351
https://bura.brunel.ac.uk/handle/2438/24351
Autor:
Gupta S; Department of Genetics, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Dovey OM; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK., Domingues AF; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Cyran OW; Department of Haematology, University of Cambridge, Cambridge, UK., Cash CM; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK., Giotopoulos G; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Rak J; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Cooper J; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Gozdecka M; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Dijkhuis L; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK., Asby RJ; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Al-Jabery N; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK., Hernandez-Hernandez V; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK.; Centre for Genome Engineering and Maintenance, Brunel University London, Uxbridge, UB8 3PH, UK., Prabakaran S; NonExomics Inc., Boston, MA, USA., Huntly BJ; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Vassiliou GS; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Pina C; College of Health, Medicine and Life Sciences - Division of Biosciences, Brunel University London, Uxbridge, UK.; Centre for Genome Engineering and Maintenance, Brunel University London, Uxbridge, UB8 3PH, UK.
Publikováno v:
Science advances [Sci Adv] 2022 Aug 05; Vol. 8 (31), pp. eabn4886. Date of Electronic Publication: 2022 Aug 03.
